CLINICAL_TRIALS
trial_result
· 2009-03-23
Clinical Trial Update: Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn [Phase 3]
Summary
Phase 3 results report the efficacy and safety of a modified-release formulation of dexlansoprazole for gastroesophageal reflux disease (heartburn).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-03-23